XML 49 R30.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Summary of Employee and Non-Employee Stock Option Activity

The following table summarizes employee and non-employee stock option activity for the year ended December 31, 2022:

 

 

 

Shares
Issuable
Under
Options

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term

 

 

Aggregate
Intrinsic
Value

 

 

 

 

 

 

 

 

 

(in years)

 

 

(in thousands)

 

Outstanding as of December 31, 2021

 

 

6,607,587

 

 

$

7.56

 

 

 

7.90

 

 

$

328

 

Granted

 

 

5,879,991

 

 

 

1.80

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(2,360,531

)

 

 

6.14

 

 

 

 

 

 

 

Outstanding as of December 31, 2022

 

 

10,127,047

 

 

$

4.55

 

 

 

6.72

 

 

$

2

 

Options vested and expected to vest as of
   December 31, 2022

 

 

9,944,309

 

 

$

4.50

 

 

 

6.78

 

 

$

2

 

Options exercisable as of December 31, 2022

 

 

4,086,256

 

 

$

6.84

 

 

 

4.93

 

 

$

 

Summary of Employee Restricted Stock Activity

The following table summarizes employee restricted stock activity for the year ended December 31, 2022:

 

 

 

Shares

 

 

Weighted
Average Grant
Date Fair Value

 

Unvested restricted stock units as of December 31, 2021

 

 

190,000

 

 

$

8.13

 

Granted

 

 

 

 

 

 

Vested

 

 

 

 

 

 

Forfeited

 

 

(48,500

)

 

 

8.13

 

Unvested restricted stock units as of December 31, 2022

 

 

141,500

 

 

$

8.13

 

Summary of Stock-Based Compensation Expense

Total stock-based compensation expense recognized from the Company’s equity incentive plans, 2018 Plan, and the 2016 ESPP for the years ended December 31, 2022, 2021, and 2020 was as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2022

 

 

2021

 

 

2020

 

 

 

Employees

 

 

Non-
Employees

 

 

Employees

 

 

Non-
Employees

 

 

Employees

 

 

Non-
Employees

 

Research and development

 

$

2,591

 

 

$

 

 

$

2,723

 

 

$

 

 

$

2,168

 

 

$

36

 

General and administrative

 

 

4,520

 

 

 

 

 

 

5,315

 

 

 

 

 

 

4,052

 

 

 

 

Total stock-based
   compensation expense

 

$

7,111

 

 

$

 

 

$

8,038

 

 

$

 

 

$

6,220

 

 

$

36

 

Summary of Weighted-Average Assumptions Used in Calculating Fair Value of Awards The following table summarizes the weighted-average assumptions used in calculating the fair value of the awards:

 

 

 

Year Ended December 31,

 

 

 

2022

 

 

2021

 

 

2020

 

Stock Options Granted

 

 

 

 

 

 

 

 

 

Expected term (in years)

 

 

6.00

 

 

 

5.99

 

 

 

6.10

 

Expected volatility

 

 

84

%

 

 

83

%

 

 

76

%

Risk-free interest

 

 

2.93

%

 

 

0.88

%

 

 

1.06

%

Dividend yield

 

 

0

%

 

 

0

%

 

 

0

%

2016 ESPP

 

 

 

 

 

 

 

 

 

Expected term (in years)

 

 

0.49

 

 

 

0.50

 

 

 

0.50

 

Expected volatility

 

 

84

%

 

 

86

%

 

 

76

%

Risk-free interest

 

 

1.95

%

 

 

0.08

%

 

 

0.75

%

Dividend yield

 

 

0

%

 

 

0

%

 

 

0

%